E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer

被引：0
|
作者：
Taofeek K. Owonikoko
Joseph Aisner
Xin Victoria Wang
Suzanne E. Dahlberg
Eric H. Rubin
Suresh S. Ramalingam
Murugesan Gounder
Paul Gregory Rausch
Rita S. Axelrod
Joan H. Schiller
机构：
[1] Emory University,Department of Biostatistics
[2] Rutgers Cancer Institute of New Jersey,Department of Biostatistics
[3] Harvard School of Public Health,undefined
[4] Dana–Farber Cancer Institute,undefined
[5] Merck Research Laboratories,undefined
[6] Frederick Memorial Hospital,undefined
[7] Thomas Jefferson University,undefined
[8] University of Texas Southwestern Medical Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
Small cell; Topoisomerase; Clinical trial; Topotecan; Irinotecan; Sequential administration; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：171 / 180
页数：9
相关论文
共 50 条
  • [31] Weekly Alternating Therapy With Irinotecan Plus Cisplatin and Etoposide Plus Cisplatin in the Treatment of Patients With Extensive Small Cell Lung Carcinoma
    William, William N., Jr.
    Uyeki, James
    Johnson, Faye M.
    Feng, Lei
    Peeples, Beverly O.
    Fossella, Frank V.
    Karp, Daniel D.
    Blumenschein, George R.
    Stewart, David J.
    Glisson, Bonnie S.
    CANCER, 2010, 116 (10) : 2409 - 2415
  • [32] A phase II study of biweekly irinotecan and cisplatin for patients with extensive stage disease small cell lung cancer
    Bae, Sung Hwa
    Ryoo, Hun Mo
    Do, Young Rok
    Song, Hong Suk
    Kwon, Ki Young
    Kim, Min Kyoung
    Lee, Kyung Hee
    Hyun, Myung Soo
    Lee, Won Sik
    Hur, In Kyong
    Baek, Jin Ho
    Park, Keon Uk
    LUNG CANCER, 2008, 59 (01) : 76 - 80
  • [33] Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI)
    Sekine, I
    Nishiwaki, Y
    Noda, K
    Kudoh, S
    Fukuoka, M
    Mori, K
    Negoro, S
    Yokoyama, A
    Matsui, K
    Ohsaki, Y
    Nakano, T
    Saijo, N
    ANNALS OF ONCOLOGY, 2003, 14 (05) : 709 - 714
  • [34] Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial
    Wu, Yuan
    Zhou, Xuefeng
    Zhao, Weiqing
    Wang, Qiong
    Han, Zhengxiang
    Wang, Lifeng
    Zhou, Wenjie
    Zhou, Tong
    Song, Haizhu
    Chen, Yong
    Yang, Kaihua
    Shi, Lin
    Pan, Banzhou
    Guo, Renhong
    Zhou, Guoren
    Jiang, Feng
    Feng, Jifeng
    Shen, Bo
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (06) : 825 - 833
  • [35] Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer
    Sun, Yan
    Cheng, Ying
    Hao, Xuezhi
    Wang, Jie
    Hu, Chengping
    Han, Baohui
    Liu, Xiaoqing
    Zhang, Li
    Wan, Huiping
    Xia, Zhongjun
    Liu, Yunpeng
    Li, Wei
    Hou, Mei
    Zhang, Helong
    Xiu, Qingyu
    Zhu, Yunzhong
    Feng, Jifeng
    Qin, Shukui
    Luo, Xiaoyan
    BMC CANCER, 2016, 16
  • [36] Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial
    Yuan Wu
    Xuefeng Zhou
    Weiqing Zhao
    Qiong Wang
    Zhengxiang Han
    Lifeng Wang
    Wenjie Zhou
    Tong Zhou
    Haizhu Song
    Yong Chen
    Kaihua Yang
    Lin Shi
    Banzhou Pan
    Renhong Guo
    Guoren Zhou
    Feng Jiang
    Jifeng Feng
    Bo Shen
    Investigational New Drugs, 2023, 41 : 825 - 833
  • [37] A Phase II Study of Carboplatin and Irinotecan in Extensive Stage Small-Cell Lung Cancer
    Horn, Leora
    Zhao, Zhiguo
    Sandler, Alan
    Johnson, David
    Shyr, Yu
    Wolff, Steven
    DeVore, Russell F.
    Laskin, Janessa
    CLINICAL LUNG CANCER, 2011, 12 (03) : 161 - 165
  • [38] A Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer
    Patrapim Sunpaweravong
    Lyn Magree
    Rachel Rabinovitch
    Paul Bunn
    Karen Kelly
    Investigational New Drugs, 2006, 24 : 213 - 221
  • [39] Three-week schedule of irinotecan plus cisplatin in patients with previously untreated extensive-stage small-cell lung cancer
    Hong, Y. S.
    Lee, H. R.
    Park, S.
    Lee, S. C.
    Hwang, I. G.
    Park, B-B
    Lee, J.
    Ahn, J. S.
    Ahn, M-J
    Lim, H. Y.
    Park, K.
    BRITISH JOURNAL OF CANCER, 2006, 95 (12) : 1648 - 1652
  • [40] A Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer
    Sunpaweravong, P
    Magree, L
    Rabinovitch, R
    Bunn, P
    Kelly, K
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (03) : 213 - 221
12345